Sosei Heptares Competitors and Similar CompaniesClear all
Sosei Heptares's competitors and similar companies include Travere Therapeutics, JCR Pharmaceuticals, GBT (Global Blood Therapeutics) and Camurus.
 Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  Camurus Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions. | ||
Founding Date | Founding Date 1990 | Founding Date 2011 | Founding Date 1975 | Founding Date 2012 | Founding Date 1991 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB | Locations San Diego, US HQ Dublin, IE | Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations Lund, SE HQ Sydney, AU Mannheim, DE Duxford, GB |
Employees | Employees 387 | Employees 46293% increase | Employees 934 | Employees 352106% increase | Employees 265 |
Valuation ($) | Valuation ($) 697 m | Valuation ($) 1.4 b | Valuation ($) 533.9 m | Valuation ($) 4.4 b | Valuation ($) 3.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥29.6b (FY, 2025) | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) ¥33.1b (FY, 2025) | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) kr2.3b (FY, 2025) |
Cost of goods | Cost of goods ¥7.3b (FY, 2025) | Cost of goods $10.3m (FY, 2025) | Cost of goods ¥8b (FY, 2025) | Cost of goods $3.3m (FY, 2021) | Cost of goods kr138.7m (FY, 2025) |
Gross profit | Gross profit ¥24b (FY, 2025) | Gross profit $480.4m (FY, 2025) | Gross profit ¥25.1b (FY, 2025) | Gross profit N/A | Gross profit kr2.1b (FY, 2025) |
Net income | Net income (¥12.5b) (FY, 2025) | Net income ($25.5m) (FY, 2025) | Net income (¥4.7b) (FY, 2025) | Net income ($303.1m) (FY, 2021) | Net income kr735.6m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 65m | Total funding raised $ 25m | Total funding raised N/A | Total funding raised $ 88.7m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Travere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View companyJCR Pharmaceuticals
HQ
Ashiya, JP
Employees
934
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
View companyGBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyCamurus
HQ
Lund, SE
Employees
265
Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.
View company